LBI-HTA - Publications - Search - [Recombinant activated C protein for severe sepsis]

Wild, C. (2005): [Recombinant activated C protein for severe sepsis]. HTA-Newsletter 38: 4.

PDF (HTA-Newsletter 38) - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader

Official URL:

Item Type:HTA Newsletter Item
Keywords:Drotrecogin alfa (Xigris®), activated C protein, drug therapy, severe sepsis, blood poisoning, safety, costs
Subjects:WC Communicable diseases
Related URLs:
References:1. NCCHTA/GB 2005: Clinical effectiveness and cost-effectiveness of drotrecogin alfa (activated) (Xigris (R)) for the treatment of severe sepsis in adults: a systematic review and economic evaluation. URL:

2. NICE/GB 2004: Drotrecogin alfa (activated) for severe sepsis. URL:

3. CAHTA/SP 2004: Assessment of the scientific evidence on the use of recombinant activated C protein – (activated) alphadrotrecogin – in severe sepsis. URL:

4. SBU/SE 2003: Drotrecogin alfa (Xigris®) for severe sepsis. URL:
Deposited on:21 Jan 2008 16:41
Last Modified:21 Jan 2008 16:41

Repository Staff Only: item control page